For patients with metachronous isolated oligometastatic cancer of gynecologic origin to the supraclavicular fossa, do you prefer standard fractionation therapy to cover the entire supraclav or SBRT to the involved nodes?
Answer from: Radiation Oncologist at Community Practice
Have preferred treating the entire region with sib boost to node.